Welcome to our dedicated page for Guardian Pharmacy Services news (Ticker: GRDN), a resource for investors and traders seeking the latest updates and insights on Guardian Pharmacy Services stock.
Guardian Pharmacy Services, Inc. (NYSE: GRDN) is a long-term care pharmacy services company based in Atlanta, Georgia. This news page aggregates company-issued updates and market-facing announcements so readers can follow how Guardian communicates about its operations, growth, and financial performance over time.
In its public news releases, Guardian highlights its role as one of the nation’s leading long-term care pharmacy services companies, partnering with long-term care facilities to deliver medications and technology-enabled services that are designed to improve adherence to drug regimens and support better clinical outcomes. The company frequently reports on revenue trends, resident counts, and Adjusted EBITDA as part of its quarterly financial results and outlook.
Typical news items for GRDN include quarterly earnings releases, guidance updates, and preliminary financial outlooks, such as reiterations of revenue and Adjusted EBITDA guidance and commentary on expected growth trajectories. Guardian also issues announcements about acquisitions and new pharmacy openings, including transactions that expand its presence into new states or strengthen its footprint in existing regions.
Investors and observers can also find capital markets updates in Guardian’s news, such as information about secondary offerings of Class A common stock, shelf registration statements on Form S-3, and lock-up agreements with pre-IPO stockholders. In addition, the company regularly announces participation in healthcare and investor conferences, where it hosts investor meetings and presentations.
By reviewing the GRDN news feed on this page, readers can track Guardian Pharmacy Services’ reported financial results, expansion activities, and other material communications disclosed through press releases and related announcements.
Guardian Pharmacy Services (NYSE: GRDN), a leading long-term care pharmacy services provider, has announced its participation in the Stephens Annual Investment Conference in Nashville. The event, scheduled for November 21, 2024, will feature a fireside chat at 9:00am CT.
Investors can access the live audio webcast through the company's investor relations website, with a replay available for approximately 60 days following the event.
Guardian Pharmacy Services (NYSE: GRDN), a major long-term care pharmacy services provider, has scheduled its Q3 2024 earnings release for Tuesday, November 12, 2024, after market close. The company will host a conference call at 4:30pm ET to discuss the results. The call will be accessible via webcast at investors.guardianpharmacy.com or by phone for both U.S. and international participants. A replay will be available for approximately 60 days following the call.
Guardian Pharmacy Services announced the pricing of its upsized initial public offering (IPO) of 8,000,000 shares of Class A common stock at $14.00 per share. The company has granted underwriters a 30-day option to purchase up to 1,200,000 additional shares at the public offering price, less the underwriting discount. Trading is expected to begin on the New York Stock Exchange on September 26, 2024, under the symbol "GRDN". The offering is set to close on September 27, 2024, subject to customary conditions.
Raymond James is the lead bookrunning manager and representative of the underwriters, with Stephens Inc. and Truist Securities acting as joint bookrunning managers. A registration statement on Form S-1 for the offering was declared effective by the SEC on September 25, 2024.